Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Arsenic exposure and prevalence of type 2 diabetes in US adults.

Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E.

JAMA. 2008 Aug 20;300(7):814-22. doi: 10.1001/jama.300.7.814.

PMID:
18714061
2.

Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population.

Navas-Acien A, Francesconi KA, Silbergeld EK, Guallar E.

Environ Res. 2011 Jan;111(1):110-8. doi: 10.1016/j.envres.2010.10.009.

3.

Urine arsenic and hypertension in US adults: the 2003-2008 National Health and Nutrition Examination Survey.

Jones MR, Tellez-Plaza M, Sharrett AR, Guallar E, Navas-Acien A.

Epidemiology. 2011 Mar;22(2):153-61. doi: 10.1097/EDE.0b013e318207fdf2.

4.

Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis.

Steinmaus C, Yuan Y, Liaw J, Smith AH.

Epidemiology. 2009 Nov;20(6):807-15. doi: 10.1097/EDE.0b013e3181b0fd29.

PMID:
19652600
5.

Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico.

Del Razo LM, García-Vargas GG, Valenzuela OL, Castellanos EH, Sánchez-Peña LC, Currier JM, Drobná Z, Loomis D, Stýblo M.

Environ Health. 2011 Aug 24;10:73. doi: 10.1186/1476-069X-10-73.

6.

Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004.

Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD.

J Expo Sci Environ Epidemiol. 2009 Jan;19(1):59-68. doi: 10.1038/jes.2008.32.

PMID:
18523458
7.

Arsenic exposure, hyperuricemia, and gout in US adults.

Kuo CC, Weaver V, Fadrowski JJ, Lin YS, Guallar E, Navas-Acien A.

Environ Int. 2015 Mar;76:32-40. doi: 10.1016/j.envint.2014.11.015.

PMID:
25499256
8.

Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico.

Coronado-González JA, Del Razo LM, García-Vargas G, Sanmiguel-Salazar F, Escobedo-de la Peña J.

Environ Res. 2007 Jul;104(3):383-9.

PMID:
17475235
9.

Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh.

Islam R, Khan I, Hassan SN, McEvoy M, D'Este C, Attia J, Peel R, Sultana M, Akter S, Milton AH.

Environ Health. 2012 Jun 7;11:38. doi: 10.1186/1476-069X-11-38.

10.

Urinary arsenic and insulin resistance in US adolescents.

Peng Q, Harlow SD, Park SK.

Int J Hyg Environ Health. 2015 Jun;218(4):407-13. doi: 10.1016/j.ijheh.2015.03.006.

11.

The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.

Zheng LY, Umans JG, Yeh F, Francesconi KA, Goessler W, Silbergeld EK, Bandeen-Roche K, Guallar E, Howard BV, Weaver VM, Navas-Acien A.

Epidemiology. 2015 Jul;26(4):601-12. doi: 10.1097/EDE.0000000000000313.

12.

Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians.

Kim NH, Mason CC, Nelson RG, Afton SE, Essader AS, Medlin JE, Levine KE, Hoppin JA, Lin C, Knowler WC, Sandler DP.

Am J Epidemiol. 2013 May 1;177(9):962-9. doi: 10.1093/aje/kws329.

13.

Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study.

Navas-Acien A, Umans JG, Howard BV, Goessler W, Francesconi KA, Crainiceanu CM, Silbergeld EK, Guallar E.

Environ Health Perspect. 2009 Sep;117(9):1428-33. doi: 10.1289/ehp.0800509.

14.

Prolonged environmental exposure of arsenic through drinking water on the risk of hypertension and type 2 diabetes.

Li X, Li B, Xi S, Zheng Q, Lv X, Sun G.

Environ Sci Pollut Res Int. 2013 Nov;20(11):8151-61. doi: 10.1007/s11356-013-1768-9.

PMID:
23649600
15.

Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia.

Guo X, Liu Z, Huang C, You L.

J Health Popul Nutr. 2006 Jun;24(2):214-20.

PMID:
17195562
16.

Evaluation of urinary speciated arsenic in NHANES: issues in interpretation in the context of potential inorganic arsenic exposure.

Aylward LL, Ramasamy S, Hays SM, Schoeny R, Kirman CR.

Regul Toxicol Pharmacol. 2014 Jun;69(1):49-54. doi: 10.1016/j.yrtph.2014.02.011.

PMID:
24582650
17.

Arsenic Exposure and Predicted 10-Year Atherosclerotic Cardiovascular Risk Using the Pooled Cohort Equations in U.S. Hypertensive Adults.

Nong Q, Zhang Y, Guallar E, Zhong Q.

Int J Environ Res Public Health. 2016 Nov 7;13(11). pii: E1093.

18.

Biological and behavioral factors modify biomarkers of arsenic exposure in a U.S. population.

Calderon RL, Hudgens EE, Carty C, He B, Le XC, Rogers J, Thomas DJ.

Environ Res. 2013 Oct;126:134-44. doi: 10.1016/j.envres.2013.04.004.

PMID:
23777639
19.

Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006.

Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E.

Epidemiology. 2009 Nov;20(6):816-20; discussion e1-2. doi: 10.1097/EDE.0b013e3181afef88. No abstract available.

20.

Association between urinary arsenic and diabetes mellitus in the Korean general population according to KNHANES 2008.

Kim Y, Lee BK.

Sci Total Environ. 2011 Sep 1;409(19):4054-62. doi: 10.1016/j.scitotenv.2011.06.003.

PMID:
21723589
Items per page

Supplemental Content

Support Center